Loading clinical trials...

Topical Simvastatin for Treating Infantile Hemangioma | Clinical Trials | Clareo Health

UNKNOWNEARLY Phase 1NCT06273111

Topical Simvastatin for Treating Infantile Hemangioma

This is a 24-week, open-label pilot study to evaluate the safety and preliminary efficacy of 5% simvastatin ointment in treating 12 children with superficial IH. The primary objective: To evaluate t...

Lead sponsor: Joyce Teng•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Joyce Teng, MD, PhD

CONTACT

650-724-9627 [email protected]

Ramrada Lekwuttikarn, MD

CONTACT

650-313-8207 [email protected]

Trial snapshot

StatusUNKNOWN

PhaseEARLY_PHASE1

Enrollment12

Start dateApr 2024

Last updatedFeb 22, 2024

Condition

Hemangioma Skin

Locations shown

Stanford University

Palo Alto, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 22, 2024Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions